Cargando…
Investigation of Novel Regulation of N-myristoyltransferase by Mammalian Target of Rapamycin in Breast Cancer Cells
Breast cancer is the most common cancer in women worldwide. Hormone receptor breast cancers are the most common ones and, about 2 out of every 3 cases of breast cancer are estrogen receptor (ER) positive. Selective ER modulators, such as tamoxifen, are the first line of endocrine treatment of breast...
Autores principales: | Jacquier, Marine, Kuriakose, Shiby, Bhardwaj, Apurva, Zhang, Yang, Shrivastav, Anuraag, Portet, Stéphanie, Varma Shrivastav, Shailly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113272/ https://www.ncbi.nlm.nih.gov/pubmed/30154572 http://dx.doi.org/10.1038/s41598-018-30447-0 |
Ejemplares similares
-
In silico identification of microRNAs predicted to regulate N-myristoyltransferase and Methionine Aminopeptidase 2 functions in cancer and infectious diseases
por: Chauhan, Ranjit, et al.
Publicado: (2018) -
N-myristoyltransferase: A potential novel diagnostic marker for colon cancer
por: Shrivastav, Anuraag, et al.
Publicado: (2007) -
N-myristoyltransferase 2–based Blood Test for the Detection of Colorectal Adenomatous Polyps and Cancer
por: Rathinagopal, Tharmini, et al.
Publicado: (2022) -
Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3): Unraveling the Role in Mediating IGF-Independent Effects Within the Cell
por: Varma Shrivastav, Shailly, et al.
Publicado: (2020) -
Insulin-Like Growth Factor Binding Protein-3 Binds to Histone 3
por: Bhardwaj, Apurva, et al.
Publicado: (2021)